$VIR
Vir Biotechnology, Inc.

2020 Q4 Form 10-K Financial Statement

#000156459021008915 Filed on February 25, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q1 2020
Revenue $1.734M $5.718M $76.37M
YoY Change 76.94% 56.19% 843.86%
Cost Of Revenue $0.00
YoY Change
Gross Profit $76.37M
YoY Change 843.86%
Gross Profit Margin 100.0%
Selling, General & Admin $23.04M $12.65M $70.94M
YoY Change 95.09% 47.78% 88.67%
% of Gross Profit 92.89%
Research & Development $87.10M $64.98M $302.4M
YoY Change 64.56% 151.16% 103.68%
% of Gross Profit 395.99%
Depreciation & Amortization $1.330M $1.000M $4.400M
YoY Change 15.65% 42.86% 33.33%
% of Gross Profit 5.76%
Operating Expenses $110.1M $77.63M $373.3M
YoY Change 70.13% 125.46% 100.65%
Operating Profit -$71.91M -$297.0M
YoY Change 133.7% 66.86%
Interest Expense $290.0K $1.760M $2.840M
YoY Change -85.13% -21.78% -66.63%
% of Operating Profit
Other Income/Expense, Net $2.440M -$5.314M $1.631M
YoY Change -234.81% -353.05% -147.28%
Pretax Income -$105.7M -$77.22M -$298.6M
YoY Change 66.11% 169.35% 71.1%
Income Tax -$30.00K $16.00K $54.00K
% Of Pretax Income
Net Earnings -$105.6M -$77.24M -$298.7M
YoY Change 65.67% 169.41% 70.98%
Net Earnings / Revenue -6092.79% -1350.82% -391.09%
Basic Earnings Per Share -$0.83 -$0.71 -$2.51
Diluted Earnings Per Share -$0.83 -$0.71 -$2.51
COMMON SHARES
Basic Shares Outstanding 109.8M 119.2M
Diluted Shares Outstanding 119.2M

Balance Sheet

Concept 2020 Q4 2020 Q1 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $736.9M $355.6M $736.9M
YoY Change 92.2% 92.2%
Cash & Equivalents $436.6M $168.4M $436.6M
Short-Term Investments $300.3M $187.2M $300.3M
Other Short-Term Assets $35.50M $21.90M $35.50M
YoY Change 81.12% 81.12%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $772.4M $377.5M $772.4M
YoY Change 91.66% 91.66%
LONG-TERM ASSETS
Property, Plant & Equipment $17.95M $16.24M $79.90M
YoY Change 10.04% 390.18%
Goodwill $16.94M
YoY Change 0.0%
Intangibles $33.82M
YoY Change -5.25%
Long-Term Investments $6.100M
YoY Change
Other Assets $15.70M $8.900M $15.70M
YoY Change -0.63% -0.63%
Total Long-Term Assets $146.4M $99.60M $146.4M
YoY Change 34.21% 34.19%
TOTAL ASSETS
Total Short-Term Assets $772.4M $377.5M $772.4M
Total Long-Term Assets $146.4M $99.60M $146.4M
Total Assets $918.8M $477.1M $918.8M
YoY Change 79.42% 79.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.077M $18.80M $5.100M
YoY Change -13.67% -13.56%
Accrued Expenses $76.70M $21.70M $76.70M
YoY Change 189.49% 191.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $200.0K $300.0K
YoY Change 50.0% 50.0%
Total Short-Term Liabilities $99.06M $56.40M $99.10M
YoY Change 67.32% 67.4%
LONG-TERM LIABILITIES
Long-Term Debt $700.0K $800.0K $700.0K
YoY Change -22.22% -22.22%
Other Long-Term Liabilities $3.847M $36.30M $98.90M
YoY Change 7.82% 300.4%
Total Long-Term Liabilities $3.847M $37.10M $99.60M
YoY Change 7.82% 289.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $99.06M $56.40M $99.10M
Total Long-Term Liabilities $3.847M $37.10M $99.60M
Total Liabilities $201.9M $96.80M $201.9M
YoY Change 129.11% 129.17%
SHAREHOLDERS EQUITY
Retained Earnings -$667.2M -$445.8M
YoY Change 81.04%
Common Stock $13.00K
YoY Change 18.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $716.9M $380.3M $716.9M
YoY Change
Total Liabilities & Shareholders Equity $918.8M $477.1M $918.8M
YoY Change 79.42% 79.42%

Cashflow Statement

Concept 2020 Q4 2020 Q1 2020
OPERATING ACTIVITIES
Net Income -$105.6M -$77.24M -$298.7M
YoY Change 65.67% 169.41% 70.98%
Depreciation, Depletion And Amortization $1.330M $1.000M $4.400M
YoY Change 15.65% 42.86% 33.33%
Cash From Operating Activities -$82.05M -$48.41M -$190.9M
YoY Change 111.03% 64.16% 47.29%
INVESTING ACTIVITIES
Capital Expenditures -$2.430M $1.302M $6.549M
YoY Change 56.77% -62.54% -26.74%
Acquisitions
YoY Change
Other Investing Activities $63.15M $105.5M -$3.310M
YoY Change -187.44% -138.98% -98.66%
Cash From Investing Activities $60.72M $104.2M -$9.862M
YoY Change -182.31% -138.01% -96.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $323.2M
YoY Change 155.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -260.0K 85.00K 529.5M
YoY Change -100.2% -99.97% 17.86%
NET CHANGE
Cash From Operating Activities -82.05M -48.41M -190.9M
Cash From Investing Activities 60.72M 104.2M -9.862M
Cash From Financing Activities -260.0K 85.00K 529.5M
Net Change In Cash -21.59M 55.90M 328.7M
YoY Change -223.72% 306.33% 417.97%
FREE CASH FLOW
Cash From Operating Activities -$82.05M -$48.41M -$190.9M
Capital Expenditures -$2.430M $1.302M $6.549M
Free Cash Flow -$79.62M -$49.71M -$197.5M
YoY Change 113.29% 50.8% 42.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 us-gaap Revenues
Revenues
10668000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100229000
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.222222222
CY2020 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019Q3 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P5Y
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesAndOtherLiabilities
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.888
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.865
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.864
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.086
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.894
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.880
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.003
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.015
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.025
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.012
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.025
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.030
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001706431
CY2020 dei Entity Registrant Name
EntityRegistrantName
Vir Biotechnology, Inc.
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127836816
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Trading Symbol
TradingSymbol
VIR
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6919000
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148472000
CY2019 us-gaap Revenues
Revenues
8091000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
302411000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37598000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29131000
CY2018 us-gaap Operating Expenses
OperatingExpenses
129360000
CY2020 us-gaap Revenues
Revenues
76368000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
70937000
CY2019 us-gaap Operating Expenses
OperatingExpenses
186070000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-118692000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-115884000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-174683000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-298665000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
892000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
451487000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122816000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59362000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
382000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
1-39083
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2730369
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
499 Illinois Street, Suite 500
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94158
CY2020 dei City Area Code
CityAreaCode
415
CY2020 dei Local Phone Number
LocalPhoneNumber
906-4324
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436575000
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
300286000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7993000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27511000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
772365000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33820000
CY2020Q4 us-gaap Goodwill
Goodwill
16937000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17946000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1278000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-667184000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
716852000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020Q2 dei Entity Public Float
EntityPublicFloat
2300000000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109335000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
274101000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6181000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13378000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
402995000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35694000
CY2019Q4 us-gaap Goodwill
Goodwill
16937000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16308000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61947000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7300000
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
24290000
CY2020Q4 us-gaap Other Assets
OtherAssets
8827000
CY2019Q4 us-gaap Other Assets
OtherAssets
8547000
CY2020Q4 us-gaap Assets
Assets
918761000
CY2019Q4 us-gaap Assets
Assets
512071000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5077000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5881000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
76936000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
26495000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6451000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6181000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10600000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8200000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
12449000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
99064000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
59206000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3815000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
12670000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66556000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
25374000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
9380000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3253000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3305000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3847000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3568000
CY2020Q4 us-gaap Liabilities
Liabilities
201909000
CY2019Q4 us-gaap Liabilities
Liabilities
88129000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127416740
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127416740
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107648925
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107648925
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
11000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1385301000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
793051000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-601000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-368519000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
423942000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
918761000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
512071000
CY2020 us-gaap Operating Expenses
OperatingExpenses
373348000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-296980000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-177979000
CY2020 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
2836000
CY2019 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
8511000
CY2018 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
2540000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4467000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5061000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-212000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1631000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3450000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2328000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-298611000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-174529000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-116364000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-480000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-298665000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-174683000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-115884000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.51
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.76
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-15.12
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
119159424
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30349920
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7666463
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-50000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
149000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14000
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-23000
CY2020 vir Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment To Projected Benefit Obligations Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentToProjectedBenefitObligationsNetOfTax
650000
CY2019 vir Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment To Projected Benefit Obligations Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentToProjectedBenefitObligationsNetOfTax
736000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-677000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-587000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-299342000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-175270000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-115898000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-68916000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
584000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5053000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-115884000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8719000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-587000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-174683000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
423942000
CY2020 vir Reclassification Of Derivative Liability To Additional Paid In Capital
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapital
29245000
CY2020 vir Stock Issued During Period Value Collaboration Agreement
StockIssuedDuringPeriodValueCollaborationAgreement
206699000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
27600000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1129000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-179177000
CY2019 vir Temporary Equity Conversion Of Convertible Preferred Stock Into Common Stock Shares
TemporaryEquityConversionOfConvertiblePreferredStockIntoCommonStockShares
88112733
CY2019 vir Temporary Equity Conversion Of Convertible Preferred Stock Into Common Stock
TemporaryEquityConversionOfConvertiblePreferredStockIntoCommonStock
636612000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
636612000
CY2019 vir Initial Public Offering Costs
InitialPublicOfferingCosts
16446000
CY2019 vir Reclassification Of Warrant Liability To Additional Paid In Capital
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital
3073000
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
3000
CY2019 vir Stock Issued During Period Value License Agreement
StockIssuedDuringPeriodValueLicenseAgreement
617000
CY2019 vir Stock Issued During Period Repayment Of Promissory Notes Net Of Unvested Common Stock Value
StockIssuedDuringPeriodRepaymentOfPromissoryNotesNetOfUnvestedCommonStockValue
1355000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
476000
CY2020 vir Common Stock Issuance Cost
CommonStockIssuanceCost
21786000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1435000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4059000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27600000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-677000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-298665000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
716852000
CY2020 us-gaap Profit Loss
ProfitLoss
-298665000
CY2019 us-gaap Profit Loss
ProfitLoss
-174683000
CY2018 us-gaap Profit Loss
ProfitLoss
-115884000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4400000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3294000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1618000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1042000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1223000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1138000
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
832000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1548000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
179000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
328000
CY2020 vir Noncash Lease Expense
NoncashLeaseExpense
3371000
CY2020 vir Change In Estimated Fair Value Of Contingent Consideration
ChangeInEstimatedFairValueOfContingentConsideration
38394000
CY2019 vir Change In Estimated Fair Value Of Contingent Consideration
ChangeInEstimatedFairValueOfContingentConsideration
8330000
CY2018 vir Change In Estimated Fair Value Of Contingent Consideration
ChangeInEstimatedFairValueOfContingentConsideration
250000
CY2020 vir Increase Decrease In Payment Of Contingent Consideration In Excess Of Acquisition Date Fair Value
IncreaseDecreaseInPaymentOfContingentConsiderationInExcessOfAcquisitionDateFairValue
-15752000
CY2019 vir Initial Fair Value Of Derivative Liability
InitialFairValueOfDerivativeLiability
13599000
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-16796000
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1150000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2049000
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
95000
CY2018 vir Preferred Stock Issued In Connection With Asset Acquisition
PreferredStockIssuedInConnectionWithAssetAcquisition
1750000
CY2019 vir Common Stock Issued In Connection With License Agreement
CommonStockIssuedInConnectionWithLicenseAgreement
617000
CY2020 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
52000
CY2018 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
480000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
8719000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
5053000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-345000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-198000
CY2020 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
23000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4475000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4619000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4172000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1100000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1881000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-151000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-790000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
964000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1471000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
46614000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
10211000
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
7171000
CY2020 vir Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3684000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7043000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3529000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7873000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-190941000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-129632000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94096000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6549000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8940000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8192000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
403841000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
643898000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
123105000
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
400348000
CY2019 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
396680000
CY2018 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
72574000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
25000
CY2018 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
1743000
CY2020 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
180000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9862000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-256158000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60441000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
323214000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
126411000
CY2019 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
317335000
CY2018 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
14254000
CY2019 vir Failed Sale Leaseback Transaction Proceeds Financing Activities
FailedSaleLeasebackTransactionProceedsFinancingActivities
1202000
CY2020 vir Payment Of Contingent Consideration
PaymentOfContingentConsideration
4248000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
250000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
95000
CY2019 vir Proceeds From Repayment Of Promissory Notes
ProceedsFromRepaymentOfPromissoryNotes
3265000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4059000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1129000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
584000
CY2019 vir Cash Paid In Lieu Of Fractional Shares In Reverse Split Of Common Stock
CashPaidInLieuOfFractionalSharesInReverseSplitOfCommonStock
3000
CY2018 vir Advanced Proceeds From Convertible Preferred Stock Financing
AdvancedProceedsFromConvertiblePreferredStockFinancing
10140000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
529474000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
449244000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24978000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
328671000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
63454000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-129559000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122816000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59362000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6919000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7300000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188921000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1996000
CY2018 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
593000
CY2019 vir Conversion Of Preferred Stock Into Common Stock Upon Completion Of Initial Public Offering
ConversionOfPreferredStockIntoCommonStockUponCompletionOfInitialPublicOffering
636612000
CY2020 vir Operating Lease Liabilities Obtained In Exchange Of Right Of Use Asset
OperatingLeaseLiabilitiesObtainedInExchangeOfRightOfUseAsset
48495000
CY2019 vir Advanced Proceeds Applied To Convertible Preferred Stock Issuance
AdvancedProceedsAppliedToConvertiblePreferredStockIssuance
10140000
CY2020 vir Reclassification Of Derivative Liability To Additional Paid In Capital Upon Achievement Of Development Milestone
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapitalUponAchievementOfDevelopmentMilestone
29245000
CY2019 vir Reclassification Of Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfPreferredStockWarrantLiabilityToAdditionalPaidInCapital
3073000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436575000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109335000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47598000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7993000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6181000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10761000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1003000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
451487000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122816000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59362000
CY2020 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On September 16, 2019, the Company’s board of directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a 1-for-4.5 reverse split (“Reverse Split”) of shares of the Company’s common and convertible preferred stock, which was effected on September 27, 2019.
CY2019Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
126400000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-667200000
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
736900000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expense during the reporting periods. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates. </p>
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the respective assets, generally three to five years.
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2020 us-gaap Finite Lived Intangible Assets Amortization Method
FiniteLivedIntangibleAssetsAmortizationMethod
Amortization is computed using the straight-line method over the estimated useful lives of the respective finite-lived intangible assets, generally seven to 15 years.
CY2020 us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Embedded Derivatives</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates its acquisitions, collaborative arrangements and other business development transactions to determine if embedded components of these contracts meet the definition of a derivative under ASC 815, Derivatives and Hedging. In general, embedded derivatives are required to be bifurcated from the host instrument if (i) the embedded feature is not clearly and closely related to the host contract and (ii) the embedded feature, if considered a freestanding instrument, meets the definition of a derivative. Embedded derivatives are reported on the consolidated balance sheets at their estimated fair values. Contingent consideration related to asset acquisitions that meet the definition of an embedded derivative is classified as contingent consideration on the consolidated balance sheets. Any change in estimated fair values, as determined at each measurement period, are recorded in the consolidated statements of operations based on the nature of the related contingencies.<span style="font-size:8pt;"> </span>Changes in fair values of embedded derivatives related to the achievement of various milestones for product candidates are recorded within research and development expense. Otherwise, changes in fair values are recorded within other income (expense), net.</p>
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q4 vir Financial Assets Amortized Cost Basis
FinancialAssetsAmortizedCostBasis
722036000
CY2020Q4 vir Financial Assets Gross Unrealized Holding Gains
FinancialAssetsGrossUnrealizedHoldingGains
91000
CY2020Q4 vir Financial Assets Gross Unrealized Holding Losses
FinancialAssetsGrossUnrealizedHoldingLosses
6000
CY2020Q4 vir Financial Assets Fair Value
FinancialAssetsFairValue
722121000
CY2019Q4 vir Financial Assets Amortized Cost Basis
FinancialAssetsAmortizedCostBasis
406883000
CY2019Q4 vir Financial Assets Gross Unrealized Holding Gains
FinancialAssetsGrossUnrealizedHoldingGains
140000
CY2019Q4 vir Financial Assets Gross Unrealized Holding Losses
FinancialAssetsGrossUnrealizedHoldingLosses
5000
CY2019Q4 vir Financial Assets Fair Value
FinancialAssetsFairValue
407018000
CY2020 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
100000
CY2019 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
100000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
12400000
CY2020Q1 vir Fair Value Reclassification Of Derivative Liability To Additional Paid In Capital Upon Achievement Of Development Milestone
FairValueReclassificationOfDerivativeLiabilityToAdditionalPaidInCapitalUponAchievementOfDevelopmentMilestone
29200000
CY2020Q4 us-gaap Goodwill
Goodwill
16900000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7502000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7000000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3581000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2539000
CY2020Q4 vir Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
832000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3089000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4461000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
532000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
532000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
532000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
260000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
213000
CY2020Q4 vir Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
2069000
CY2020Q4 vir Finite Lived Intangible Assets Reclassified From Indefinite Lived
FiniteLivedIntangibleAssetsReclassifiedFromIndefiniteLived
500000
CY2020 vir Collaboration Agreement Termination Description
CollaborationAgreementTerminationDescription
the WuXi Biologics Collaboration Agreement may be terminated by (i) the written agreement of both parties, (ii) WuXi Biologics following the one year anniversary of the WuXi Biologics Collaboration Agreement effective date with respect to the entire agreement or on a product by product basis with 90 days’ prior written notice or (iii) by either party if the other party materially breaches the WuXi Biologics Collaboration Agreement and fails to cure such breach within sixty days.
CY2019Q4 vir Restricted Stock Liability Current
RestrictedStockLiabilityCurrent
1434000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
265000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9232000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4832000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17946000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16308000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4400000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3300000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1600000
CY2019Q3 vir Sale Leaseback Transaction Proceeds From Financing Obligations
SaleLeasebackTransactionProceedsFromFinancingObligations
1200000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
300000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27178000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21140000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
700000
CY2020Q4 vir Research And Development Expenses Current
ResearchAndDevelopmentExpensesCurrent
49384000
CY2019Q4 vir Research And Development Expenses Current
ResearchAndDevelopmentExpensesCurrent
12530000
CY2020Q4 vir Payroll And Related Expenses Current
PayrollAndRelatedExpensesCurrent
17060000
CY2019Q4 vir Payroll And Related Expenses Current
PayrollAndRelatedExpensesCurrent
9410000
CY2020Q4 vir Excess Funds Payable Under Grant Agreements Current
ExcessFundsPayableUnderGrantAgreementsCurrent
3467000
CY2019Q4 vir Excess Funds Payable Under Grant Agreements Current
ExcessFundsPayableUnderGrantAgreementsCurrent
94000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3625000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
237000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2595000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1634000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
540000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1156000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
76936000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
26495000
CY2020 vir Lease Arrangement Contractual Expiration Beginning Year
LeaseArrangementContractualExpirationBeginningYear
2021
CY2020 vir Lease Arrangement Contractual Expiration Ending Year
LeaseArrangementContractualExpirationEndingYear
2033
CY2020 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain lease agreements also provide the Company with the option to renew for additional periods ranging from three months to five years.
CY2020Q4 us-gaap Tenant Improvements
TenantImprovements
10500000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
4591000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
459000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
2299000
CY2020 us-gaap Lease Cost
LeaseCost
7349000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y7M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.077
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
5100000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48500000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6247000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9725000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11399000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10576000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8054000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
67503000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
113504000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
40949000
CY2020Q4 vir Lessee Operating Lease Liability Net Tenant Improvement Allowance Yet To Be Received
LesseeOperatingLeaseLiabilityNetTenantImprovementAllowanceYetToBeReceived
10287000
CY2020Q4 vir Present Value Of Operating Lease Liabilities
PresentValueOfOperatingLeaseLiabilities
62268000
CY2020Q4 vir Operating Lease Liability Current Net Of Tenant Improvement Allowances Included In Prepaid
OperatingLeaseLiabilityCurrentNetOfTenantImprovementAllowancesIncludedInPrepaid
7913000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61947000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3625000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66556000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
70181000
CY2019 vir Operating And Finance Rent Expense
OperatingAndFinanceRentExpense
4400000
CY2018 vir Operating And Finance Rent Expense
OperatingAndFinanceRentExpense
4000000.0
CY2016Q3 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2026-09-11
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
159891000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27600000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8719000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5053000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9887543
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9506253
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
80014621
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1800000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1200000
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
700000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-309697000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-138724000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-110399000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
11086000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-35805000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5965000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-298611000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-174529000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-116364000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
106000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
154000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
20000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
106000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
154000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-21000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-445000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-31000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-55000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-52000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-500000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-480000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.009
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.003
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.019
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.027
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.024
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.020
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.018
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.020
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.022
CY2018 vir Effective Income Tax Rate Reconciliation In Process Research And Development Percent
EffectiveIncomeTaxRateReconciliationInProcessResearchAndDevelopmentPercent
-0.029
CY2020 vir Effective Income Tax Rate Reconciliation Permanent Items Percent
EffectiveIncomeTaxRateReconciliationPermanentItemsPercent
0.013
CY2019 vir Effective Income Tax Rate Reconciliation Permanent Items Percent
EffectiveIncomeTaxRateReconciliationPermanentItemsPercent
-0.008
CY2018 vir Effective Income Tax Rate Reconciliation Permanent Items Percent
EffectiveIncomeTaxRateReconciliationPermanentItemsPercent
-0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.234
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.243
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.214
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
23006000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
9733000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
183866000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
92706000
CY2020Q4 vir Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
16147000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2570000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1553000
CY2020Q4 vir Deferred Tax Liabilities In Process Research And Development
DeferredTaxLiabilitiesInProcessResearchAndDevelopment
8511000
CY2019Q4 vir Deferred Tax Liabilities In Process Research And Development
DeferredTaxLiabilitiesInProcessResearchAndDevelopment
8647000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
27228000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10200000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2404000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
117433000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
67493000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12246000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6978000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4193000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1514000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
10804000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
6988000
CY2020Q4 vir Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
16184000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85811000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3253000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3305000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
74100000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
42300000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
26000000.0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4900000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2700000
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
37817000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
49083000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
64739000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-28670000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-33928000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-48314000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-63771000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.19
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2725000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2404000
CY2020Q1 us-gaap Revenues
Revenues
5718000
CY2020Q2 us-gaap Revenues
Revenues
66988000
CY2020Q3 us-gaap Revenues
Revenues
1928000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.64
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
272000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
133000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
32000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
588000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1596000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
215000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2740000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1784000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2315000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4877000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2725000
CY2020Q4 us-gaap Revenues
Revenues
1734000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
77628000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
96039000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
89543000
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
110138000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-77240000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-31167000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-84609000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-105649000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2019Q1 us-gaap Revenues
Revenues
3661000
CY2019Q2 us-gaap Revenues
Revenues
2047000
CY2019Q3 us-gaap Revenues
Revenues
1403000
CY2019Q4 us-gaap Revenues
Revenues
980000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
34431000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.60
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.19
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.64
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.60
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71

Files In Submission

Name View Source Status
0001564590-21-008915-index-headers.html Edgar Link pending
0001564590-21-008915-index.html Edgar Link pending
0001564590-21-008915.txt Edgar Link pending
0001564590-21-008915-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
goiuo01shaze000001.jpg Edgar Link pending
grteolgdzg42000001.jpg Edgar Link pending
grteolgdzg42000002.jpg Edgar Link pending
grteolgdzg42000003.jpg Edgar Link pending
grteolgdzg42000004.jpg Edgar Link pending
grteolgdzg42000005.jpg Edgar Link pending
grteolgdzg42000006.jpg Edgar Link pending
grteolgdzg42000007.jpg Edgar Link pending
grteolgdzg42000008.jpg Edgar Link pending
grteolgdzg42000009.jpg Edgar Link pending
grteolgdzg42000010.jpg Edgar Link pending
grteolgdzg42000011.jpg Edgar Link pending
grteolgdzg42000012.jpg Edgar Link pending
grteolgdzg42000013.jpg Edgar Link pending
grteolgdzg42000014.jpg Edgar Link pending
grteolgdzg42000015.jpg Edgar Link pending
grteolgdzg42000016.jpg Edgar Link pending
grteolgdzg42000017.jpg Edgar Link pending
grteolgdzg42000018.jpg Edgar Link pending
grteolgdzg42000019.jpg Edgar Link pending
grteolgdzg42000020.jpg Edgar Link pending
grteolgdzg42000021.jpg Edgar Link pending
grteolgdzg42000022.jpg Edgar Link pending
grteolgdzg42000023.jpg Edgar Link pending
grteolgdzg42000024.jpg Edgar Link pending
grteolgdzg42000025.jpg Edgar Link pending
grteolgdzg42000026.jpg Edgar Link pending
grteolgdzg42000027.jpg Edgar Link pending
grteolgdzg42000028.jpg Edgar Link pending
grteolgdzg42000029.jpg Edgar Link pending
grteolgdzg42000030.jpg Edgar Link pending
grteolgdzg42000031.jpg Edgar Link pending
grteolgdzg42000032.jpg Edgar Link pending
grteolgdzg42000033.jpg Edgar Link pending
grteolgdzg42000034.jpg Edgar Link pending
grteolgdzg42000035.jpg Edgar Link pending
grteolgdzg42000036.jpg Edgar Link pending
grteolgdzg42000037.jpg Edgar Link pending
grteolgdzg42000038.jpg Edgar Link pending
grteolgdzg42000039.jpg Edgar Link pending
grteolgdzg42000040.jpg Edgar Link pending
grteolgdzg42000041.jpg Edgar Link pending
grteolgdzg42000042.jpg Edgar Link pending
grteolgdzg42000043.jpg Edgar Link pending
grteolgdzg42000044.jpg Edgar Link pending
grteolgdzg42000045.jpg Edgar Link pending
grteolgdzg42000046.jpg Edgar Link pending
grteolgdzg42000047.jpg Edgar Link pending
grteolgdzg42000048.jpg Edgar Link pending
grteolgdzg42000049.jpg Edgar Link pending
grteolgdzg42000050.jpg Edgar Link pending
grteolgdzg42000051.jpg Edgar Link pending
grteolgdzg42000052.jpg Edgar Link pending
grteolgdzg42000053.jpg Edgar Link pending
grteolgdzg42000054.jpg Edgar Link pending
grteolgdzg42000055.jpg Edgar Link pending
grteolgdzg42000056.jpg Edgar Link pending
grteolgdzg42000057.jpg Edgar Link pending
grteolgdzg42000058.jpg Edgar Link pending
grteolgdzg42000059.jpg Edgar Link pending
grteolgdzg42000060.jpg Edgar Link pending
grteolgdzg42000061.jpg Edgar Link pending
grteolgdzg42000062.jpg Edgar Link pending
grteolgdzg42000063.jpg Edgar Link pending
grteolgdzg42000064.jpg Edgar Link pending
grteolgdzg42000065.jpg Edgar Link pending
grteolgdzg42000066.jpg Edgar Link pending
grteolgdzg42000067.jpg Edgar Link pending
grteolgdzg42000068.jpg Edgar Link pending
grteolgdzg42000069.jpg Edgar Link pending
grteolgdzg42000070.jpg Edgar Link pending
grteolgdzg42000071.jpg Edgar Link pending
grteolgdzg42000072.jpg Edgar Link pending
grteolgdzg42000073.jpg Edgar Link pending
grteolgdzg42000074.jpg Edgar Link pending
grteolgdzg42000075.jpg Edgar Link pending
grteolgdzg42000076.jpg Edgar Link pending
grteolgdzg42000077.jpg Edgar Link pending
grteolgdzg42000078.jpg Edgar Link pending
grteolgdzg42000079.jpg Edgar Link pending
grteolgdzg42000080.jpg Edgar Link pending
grteolgdzg42000081.jpg Edgar Link pending
grteolgdzg42000082.jpg Edgar Link pending
grteolgdzg42000083.jpg Edgar Link pending
grteolgdzg42000084.jpg Edgar Link pending
grteolgdzg42000085.jpg Edgar Link pending
grteolgdzg42000086.jpg Edgar Link pending
grteolgdzg42000087.jpg Edgar Link pending
grteolgdzg42000088.jpg Edgar Link pending
grteolgdzg42000089.jpg Edgar Link pending
grteolgdzg42000090.jpg Edgar Link pending
grteolgdzg42000091.jpg Edgar Link pending
grteolgdzg42000092.jpg Edgar Link pending
grteolgdzg42000093.jpg Edgar Link pending
grteolgdzg42000094.jpg Edgar Link pending
grteolgdzg42000095.jpg Edgar Link pending
grteolgdzg42000096.jpg Edgar Link pending
grteolgdzg42000097.jpg Edgar Link pending
grteolgdzg42000098.jpg Edgar Link pending
grteolgdzg42000099.jpg Edgar Link pending
grteolgdzg42000100.jpg Edgar Link pending
grteolgdzg42000101.jpg Edgar Link pending
grteolgdzg42000102.jpg Edgar Link pending
grteolgdzg42000103.jpg Edgar Link pending
grteolgdzg42000104.jpg Edgar Link pending
grteolgdzg42000105.jpg Edgar Link pending
grteolgdzg42000106.jpg Edgar Link pending
grteolgdzg42000107.jpg Edgar Link pending
grteolgdzg42000108.jpg Edgar Link pending
grteolgdzg42000109.jpg Edgar Link pending
grteolgdzg42000110.jpg Edgar Link pending
grteolgdzg42000111.jpg Edgar Link pending
grteolgdzg42000112.jpg Edgar Link pending
grteolgdzg42000113.jpg Edgar Link pending
grteolgdzg42000114.jpg Edgar Link pending
grteolgdzg42000115.jpg Edgar Link pending
grteolgdzg42000116.jpg Edgar Link pending
grteolgdzg42000117.jpg Edgar Link pending
grteolgdzg42000118.jpg Edgar Link pending
grteolgdzg42000119.jpg Edgar Link pending
grteolgdzg42000120.jpg Edgar Link pending
grteolgdzg42000121.jpg Edgar Link pending
grteolgdzg42000122.jpg Edgar Link pending
grteolgdzg42000123.jpg Edgar Link pending
grteolgdzg42000124.jpg Edgar Link pending
grteolgdzg42000125.jpg Edgar Link pending
grteolgdzg42000126.jpg Edgar Link pending
grteolgdzg42000127.jpg Edgar Link pending
grteolgdzg42000128.jpg Edgar Link pending
grteolgdzg42000129.jpg Edgar Link pending
grteolgdzg42000130.jpg Edgar Link pending
grteolgdzg42000131.jpg Edgar Link pending
grteolgdzg42000132.jpg Edgar Link pending
grteolgdzg42000133.jpg Edgar Link pending
grteolgdzg42000134.jpg Edgar Link pending
grteolgdzg42000135.jpg Edgar Link pending
grteolgdzg42000136.jpg Edgar Link pending
grteolgdzg42000137.jpg Edgar Link pending
grteolgdzg42000138.jpg Edgar Link pending
grteolgdzg42000139.jpg Edgar Link pending
grteolgdzg42000140.jpg Edgar Link pending
grteolgdzg42000141.jpg Edgar Link pending
grteolgdzg42000142.jpg Edgar Link pending
grteolgdzg42000143.jpg Edgar Link pending
gtpwgju1lmon000001.jpg Edgar Link pending
gtpwgju1lmon000002.jpg Edgar Link pending
gtpwgju1lmon000003.jpg Edgar Link pending
gtpwgju1lmon000004.jpg Edgar Link pending
gtpwgju1lmon000005.jpg Edgar Link pending
gtpwgju1lmon000006.jpg Edgar Link pending
gtpwgju1lmon000007.jpg Edgar Link pending
gtpwgju1lmon000008.jpg Edgar Link pending
gtpwgju1lmon000009.jpg Edgar Link pending
gtpwgju1lmon000010.jpg Edgar Link pending
gtpwgju1lmon000011.jpg Edgar Link pending
gtpwgju1lmon000012.jpg Edgar Link pending
gtpwgju1lmon000013.jpg Edgar Link pending
gtpwgju1lmon000014.jpg Edgar Link pending
gtpwgju1lmon000015.jpg Edgar Link pending
gtpwgju1lmon000016.jpg Edgar Link pending
gtpwgju1lmon000017.jpg Edgar Link pending
gtpwgju1lmon000018.jpg Edgar Link pending
gtpwgju1lmon000019.jpg Edgar Link pending
gtpwgju1lmon000020.jpg Edgar Link pending
gtpwgju1lmon000021.jpg Edgar Link pending
gtpwgju1lmon000022.jpg Edgar Link pending
gtpwgju1lmon000023.jpg Edgar Link pending
gtpwgju1lmon000024.jpg Edgar Link pending
gtpwgju1lmon000025.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vir-10k_20201231.htm Edgar Link pending
vir-10k_20201231_htm.xml Edgar Link completed
vir-20201231.xsd Edgar Link pending
vir-20201231_cal.xml Edgar Link unprocessable
vir-20201231_def.xml Edgar Link unprocessable
vir-20201231_lab.xml Edgar Link unprocessable
vir-20201231_pre.xml Edgar Link unprocessable
vir-ex1024_828.htm Edgar Link pending
vir-ex1029_829.htm Edgar Link pending
vir-ex1038_490.htm Edgar Link pending
vir-ex1039_491.htm Edgar Link pending
vir-ex1051_886.htm Edgar Link pending
vir-ex105_2690.htm Edgar Link pending
vir-ex1061_887.htm Edgar Link pending
vir-ex108_229.htm Edgar Link pending
vir-ex231_6.htm Edgar Link pending
vir-ex311_8.htm Edgar Link pending
vir-ex312_9.htm Edgar Link pending
vir-ex321_10.htm Edgar Link pending